» Authors » Mariana Tome Fernandez-Ladreda

Mariana Tome Fernandez-Ladreda

Explore the profile of Mariana Tome Fernandez-Ladreda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 96
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Araujo-Castro M, Garcia Sanz I, Minguez Ojeda C, Hanzu F, Mora M, Vicente A, et al.
Front Endocrinol (Lausanne) . 2023 Dec; 14:1279828. PMID: 38155946
Purpose: To evaluate the rate of recurrence among patients with pheochromocytomas and sympathetic paragangliomas (PGLs; together PPGLs) and to identify predictors of recurrence (local recurrence and/or metastatic disease). Methods: This...
2.
Araujo-Castro M, Garcia Sanz I, Minguez Ojeda C, Hanzu F, Mora M, Vicente A, et al.
J Hypertens . 2023 Oct; 42(2):252-259. PMID: 37851004
Purpose: To identify presurgical and surgical risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas (PGLs) (PPGLs). Methods: Retrospective multicenter cohort study of patients with PPGLs...
3.
Araujo-Castro M, Garcia Sanz I, Minguez Ojeda C, Calatayud M, Hanzu F, Mora M, et al.
Cancers (Basel) . 2023 Jul; 15(14). PMID: 37509397
Purpose: to perform an external validation of our predictive model to rule out pheochromocytoma (PHEO) based on unenhanced CT in a cohort of patients with PHEOs and adenomas who underwent...
4.
Araujo-Castro M, Minguez Ojeda C, Garcia Sanz I, Calatayud M, Hanzu F, Mora M, et al.
Neuroendocrinology . 2023 Jan; 113(6):657-666. PMID: 36693324
Introduction: It is estimated that 30-40% of patients with apparently sporadic pheochromocytomas (PHEOs) have an inherited predisposition syndrome. The aim of our study was to develop a predictive model of...
5.
Araujo-Castro M, Parra Ramirez P, Martin Rojas-Marcos P, Garcia Centeno R, Gracia Gimeno P, Tome Fernandez-Ladreda M, et al.
Endocrine . 2022 Oct; 79(2):384-391. PMID: 36261701
Purpose: To analyze the differences in the cardiometabolic profile in patients with nonfunctioning adrenal incidentalomas (NFAI) with post-dexamethasone suppression test (DST) cortisol ≤1.4 µg/dL (NFAI ≤ 1.4) and those with...
6.
Araujo-Castro M, Garcia Centeno R, Robles Lazaro C, Parra Ramirez P, Gracia Gimeno P, Martin Rojas-Marcos P, et al.
Sci Rep . 2022 Feb; 12(1):2671. PMID: 35177692
The purpose of our study was to develop a predictive model to rule out pheochromocytoma among adrenal tumours, based on unenhanced computed tomography (CT) and/or magnetic resonance imaging (MRI) features....
7.
Araujo-Castro M, Parra Ramirez P, Robles Lazaro C, Garcia Centeno R, Gracia Gimeno P, Tome Fernandez-Ladreda M, et al.
J Clin Med . 2021 Dec; 10(23). PMID: 34884211
Purpose: To assess the risk of developing autonomous cortisol secretion (ACS) and tumour growth in non-functioning adrenal incidentalomas (NFAIs). Methods: Multicentre retrospective observational study of patients with NFAIs. ACS was...
8.
Araujo-Castro M, Garcia Centeno R, Lopez-Garcia M, Lamas C, Alvarez-Escola C, Gutierrez M, et al.
Endocr Relat Cancer . 2021 Aug; 28(11):695-703. PMID: 34379605
We aimed to identify presurgical and surgical risk factors for intraoperative complications in patients with pheochromocytomas. A retrospective study of patients with pheochromocytomas who underwent surgery in ten Spanish hospitals...
9.
Araujo-Castro M, Garcia Centero R, Lopez-Garcia M, Alvarez Escola C, Gutierrez M, Blanco Carrera C, et al.
Endocrine . 2021 Aug; 74(3):676-684. PMID: 34373995
Purpose: To identify presurgical and surgical risk factors for postsurgical complications in the pheochromocytoma surgery. Methods: A retrospective study of pheochromocytomas submitted to surgery in ten Spanish hospitals between 2011...
10.
Araujo-Castro M, Parra Ramirez P, Robles Lazaro C, Garcia Centeno R, Gracia Gimeno P, Tome Fernandez-Ladreda M, et al.
Hormones (Athens) . 2021 Jul; 20(4):735-744. PMID: 34273083
Purpose: The aim of this study was to evaluate the diagnostic accuracy of the 1 mg dexamethasone suppression test (DST) for the prediction of autonomous cortisol secretion (ACS)-related comorbidities in...